Introduction {#S0001}
============

Intrastromal corneal ring segments (ICRS) are small crescent-shaped pieces of synthetic material that are implanted deep in the corneal stroma in order to modify the corneal curvature and achieve refractive changes. Several studies have demonstrated the efficacy of ICRS in correcting low myopia, in post-laser in situ keratomileusis corneal ectasia, and in keratoconic eyes.[@CIT0001]--[@CIT0005] When combined with a CXL procedure, these segments can support a keratoconic cornea and improve vision, while CXL prevents the ectasia progression.[@CIT0005]

Polymethyl-methacrylate (PMMA), a biocompatible material widely used in ophthalmology, is currently used to produce the above-mentioned ring segments (PMMA used in INTACS-Addition technology, CA, USA). Despite PMMA's biocompatibility, various complications of PMMA ICRS have been reported in the literature.[@CIT0009]

Allograft tissue ICRS have been reported as a feasible alternative.[@CIT0010] A xenograft biological tissue-derived ICRS that would be devoid of biocompatibility complications has not been introduced yet. The purpose of this paper is to introduce the idea of using porcine cornea in order to create ring segments and to test this preliminary idea by implanting them in a human cadaver cornea (Ex vivo).

Materials and Methods {#S0002}
=====================

This study received prior approval from the Laservision Clinical and Research Institute, ethics committee, and did not involve study in live human or animal subjects. The use and disposal of all human and porcine cadaver tissue were according to the declaration of Helsinki.

The dissection of ICRS from freeze-dried gamma-irradiated porcine corneas (CRMI, Wanchai, Hong Kong) as well as the subsequent implantation to a human cadaver cornea took place in our institutions laboratory facilities, and were performed by one surgeon (AJK).

This novel method aims to create ICRS out of porcine corneas (xenografts) instead of PMMA or human allograft donor tissue. The xenograft was dissected with the FS200 femtosecond laser. Two ring segments were dissected from the xenograft, in order to cover a total of 300 degrees. Each segment parameters were:

Arc length: 150 degrees,

Cross-section shape: square,

Thickness (mm): 0.45,

Inner radius: 6.8mm,

Outer radius 8.10mm.

An ex-vivo human cadaver cornea was gamma irradiated and placed in a single-use artificial chamber (Katena Products, Parsippany, NJ, USA) in order to conduct the pre-and post-operative tomography with the Scheimpflug and OCT devices, and to conduct the xenograft ICRS implantation and CXL combined procedures.

The WaveLight FS200 femtosecond laser (Alcon, Ft. Worth, TX) was used to create the circular channel into which the ICRS would be implanted. The settings are pre-set and illustrated in [Figure 1](#F0001){ref-type="fig"}. Specifically for the lamellar channel creation: the outer diameter dissection was set at 8.0mm; the inner diameter at 5.5mm; the depth at 500 micrometers. The vertical incision was set at 1.5mm length, 1.5mm width, and arc position of 0 degrees, as also illustrated in [Figure 1](#F0001){ref-type="fig"}. The increased precision of this laser allowed the creation of a well-defined circular insertion channel, preventing digressions to false pathways within the cornea during the ring segment insertion. The insertion point was marked manually on the cornea, and the INTACS channel maker was applied into the femto laser-created channels, in order to complete the path for the implantation. The corneal channel had the following parameters: outer diameter 8 mm, inner diameter 5.5 mm, width 2.5 mm and depth 500 um. The platform length and width were 1.5 mm and 0-degree of incision position. The parameters used on the femtosecond laser are illustrated in [Figure 1](#F0001){ref-type="fig"}, images A through C. The thinnest pachymetry of the cornea was 750 µm.Figure 1**(A**--**C)** Corneal channel dissection parameters programmed into the Alcon/WaveLight FS200 femtosecond laser. (**D**) Anterior segment OCT illustrates the -- as planned -- position within the host cornea, of the implanted xenograft intracorneal ring segments.

Both rings were implanted in a similar fashion to INTACS,[@CIT0005] with the assistance of forceps. The porcine ICRS were visualized with the operating room slit lamp assessed to be well positioned.

Following implantation, an enhanced corneal crosslinking (CXL) procedure was applied. The channels containing the porcine segments were filled with VibeX Xtra 0.25% riboflavin solution (Avedro, Waltham, Massachusetts), which is a much more highly concentrated solution than the one described in the classic Dresden protocol.[@CIT0011] Once the riboflavin solution was instilled in the channels, higher-fluence UV radiation (30 mW/cm^2^) for total 7.2 joules was delivered on the corneal (cadaver cornea with the xenograft ICRS implanted) surface with the KXL I device (Avedro, Waltham, MA, USA). Once the riboflavin solution was instilled in the channels,  higher-fluence UV radiation (30 mW/cm^2^) for total 7.2 joules was delivered on the corneal (cadaver cornea with the xenograft ICRS implanted) surface with the KXL I device (Avedro, Waltham, MA, USA).

The Fourier-domain Anterior Segment -- Optical Coherence Tomography (AS-OCT) system RTVue 100 (Optovue Inc., Fremont, CA, USA), Scheimplug tomography (Pentacam Scheimpﬂug imaging device Oculyzer II, WaveLight AG, Erlangen, Germany) and Placido-disc topography (Alcon/WaveLight Allegro Topolyzer Vario, WaveLight AG, Erlangen, Germany) were used to visualize and assess the positioning and refractive changes following the CXL procedure as seen in image D of [Figure 1](#F0001){ref-type="fig"}.

Results {#S0003}
=======

Pre-operative cadaver cornea keratometry was 44.8 Diopters in the cornea apex and revealed 1.6 Diopters of astigmatism: steep keratometry 44.8 Diopters at 45 degrees steep axis, and flat keratometry 43.2 diopters at 135 degrees flat axis. Postoperatively: The position of the ICRS was established. The anterior segment OCT showed well-positioned ICRS with an intact central corneal region ([Figure 1D](#F0001){ref-type="fig"}). The Scheimpflug comparative tomography images revealed a significant flattening of up to 7 Diopters (7.21 Diopters flattening) on the corneal apex after the procedure as illustrated in the anterior curvature maps in [Figure 2](#F0002){ref-type="fig"}, documenting the flattening achieved in the left image 2A, the pre-op anterior curvature in image 2B upper right, and the post-xenograft ICRS implantation combined with high fluence CXL in image 2C lower right. Specifically the post-operative keratometries were: Cornea apex: 35.7 diopters; steep keratometry 35.7 at 30 degrees; flat keratometry 30.5 diopters at 120 degrees.Figure 2These images illustrate the Placido-disc topographic changes documented in this ex-vivo procedure. Specifically: (**A**) reflects the difference flattering achieved (an impressive 7 Diopters) with the combined ICRS xenograft and CXL from (**B**) pre-operative to (**C**) post-operative.

Discussion {#S0004}
==========

The use of intralamellar homoplasty in the cornea, in order to achieve refractive flattening and is old, and the first report dates back from 1966![@CIT0012]

Intracorneal ring segments (ICRS) were initially introduced and used clinically for an alternative corneal-based refractive procedure in order to reduce myopia and/or astigmatism. Following initial clinical acceptance for this purpose, its use in healthy, myopic eyes has subsided and instead they have been used extensively in corneal ectasia as a therapeutic intervention. Specifically patients ill-suited for interventions involving corneal ablation, as in thinned keratoconic corneas. These ring segments were implanted in the corneal stroma and their role was to flatten the steep part of the cornea and improve visual acuity.[@CIT0001],[@CIT0002] With ICRS implantation, no elimination of corneal tissue is required and the changes induced in the corneal shape are reversible -- the cornea nearly returns to its original state in case the segments are explanted.[@CIT0007]

Currently, ICRS are commonly used to flatten misshapen areas of irregular corneas, which has been proven to be a beneficial treatment for patients with keratoconus and post-LASIK keratectasia. These small crescent-shaped implants function by flattening the central corneal curvature while maintaining clarity in the central optic zone.[@CIT0004] When used for keratoconus (or keratectasia), they are often coupled with corneal crosslinking (CXL) to enhance the biomechanical characteristics of the corneal stroma along with the ICRS-mediated correction the visual impairment.[@CIT0005]

The biocompatible PMMA material that is currently used to create ICRS is not devoid of complications. These mainly concern the actual stability of the ring segments in the cornea, their movement as well as exposure through the axial wound. Significant corneal thinning, potential risks of intrastromal ring segment corneal extrusion, infection, corneal melt and corneal infiltrate have also been reported by us and other groups.[@CIT0006],[@CIT0008],[@CIT0009] These complications may relate to the difference in biomechanical properties between the rigid and impermeable PMMA material used when compared to the host stromal tissue consisting mainly of collagen. Biological tissue-made ICRS, such as allograft or even xenograft corneal stroma, would potentially be more stable and allow nourishment flow through the cornea stroma of the cornea, as they would resemble a biomechanically supporting biological implant in the cornea.

In this ex-vivo experimental work, two ICRS resembling in parameters the "largest" commercially available INTACT were dissected from a porcine cornea and then implanted in a normal, not keratoconic, human cadaver host cornea. The procedure was followed by an enhanced CXL protocol. Images from OCT showed satisfactory positioning of the segments while the tomography showed significant flattening of the central 6mm of the cornea.

As a single-case presentation, this study does not describe elaborative data accomplished with this technique. It does though demonstrate feasibility in an ex-vivo setting and potential application in-vivo and in potentially ectatic corneas such as keratoconus. These results should enhance the continuation of experimental work in order to proceed in clinical trials and the formation of a new protocol, which will hopefully produce better ICRS with improved biocompatibility and fewer complications.
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